A 48-year-old man on ICU has severe intra-abdominal sepsis requiring prolonged antibiotic therapy with IV meropenem. The team wishes to optimise meropenem efficacy using a pharmacokinetic/pharmacodynamic (PK/PD) approach. Meropenem exhibits time-dependent killing. What dosing strategy best exploits this PK/PD property?